DCSIMG
SWTS.news.image.e

Scots board mulls prostate drug use

SCOTLAND’S drugs advisory board is considering whether to recommend use of a prostate treatment hailed as a breakthrough after it was deemed too expensive for use by the NHS south of the Border.

The National Institute for Health and Clinical Excellence (Nice) has ruled that abiraterone, also called Zytiga, is too expensive.

The drug has been seen as a success story in extending the lives of men with late-stage prostate cancer. Cancer Research UK said the draft decision by Nice – which is still open to consultation – made “no sense” and Nice had used the wrong criteria to judge the drug.

Nice has ruled that although abiraterone is clinically effective, it is not good value for money. In Scotland, the Scottish Medicines Consortium, advises on whether drugs should be used by the NHS. Its advice will be published in March.


Find It

"Business owner? - Claim your business and Advertise with us"

In association with qype logo

Looking for...

Featured advertisers

Jobs

Search for a job

Motors

Search for a car

Property

Search for a house

Weather for Edinburgh

Sunday 27 May 2012

5 day forecast

Today

Sunny

Sunny

Temperature: 10 C to 22 C

Wind Speed: 12 mph

Wind direction: North east

Tomorrow

Sunny

Sunny

Temperature: 9 C to 21 C

Wind Speed: 12 mph

Wind direction: North east

Press Complaints Commission

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.

Scotsman.com provides news, events and sport features from the Edinburgh area. For the best up to date information relating to Edinburgh and the surrounding areas visit us at Scotsman.com regularly or bookmark this page.